Adaptimmune Therapeutics plc (ADAP)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Strong Sell

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

20

0

4

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
17-Jan-24 5:30 PM View:	17-Jan-24 Sale ($12.73K)	Bertrand William C Jr Chief Operating Officer		Adaptimmune Therapeutics plc - ADAP	100% 10.11K to 20.2K	0	0	--	--	Show Txns Hide Txns

17-Jan-24 5:30 PM View:	17-Jan-24 Sale ($12.19K)	Lunger John Chief Patient Supply Officer		Adaptimmune Therapeutics plc - ADAP	88% 10.11K to 19.02K	0	0	--	--	Show Txns Hide Txns

17-Jan-24 5:31 PM View:	17-Jan-24 Sale ($20.24K)	Rawcliffe Adrian Chief Executive Officer Director		Adaptimmune Therapeutics plc - ADAP	48% 30.34K to 44.85K	0	0	--	--	Show Txns Hide Txns

17-Jan-24 5:31 PM View:	17-Jan-24 Sale ($12.30K)	Norry Elliot Chief Medical Officer		Adaptimmune Therapeutics plc - ADAP	90% 10.11K to 19.26K	0	0	--	--	Show Txns Hide Txns

18-Jun-24 5:00 PM View:	18-Jun-24 Sale ($22.81K)	Piccina Cintia Chief Commercial Officer		Adaptimmune Therapeutics plc - ADAP	(39%) 62.82K to 38.29K	0	0	--	--	Show Txns Hide Txns